Growth Metrics

Fortress Biotech (FBIO) Profit After Tax (2016 - 2025)

Fortress Biotech has reported Profit After Tax over the past 13 years, most recently at -$43.7 million for Q4 2025.

  • Quarterly results put Profit After Tax at -$43.7 million for Q4 2025, down 65.94% from a year ago — trailing twelve months through Dec 2025 was -$57.1 million (up 52.77% YoY), and the annual figure for FY2025 was -$32.9 million, up 72.76%.
  • Profit After Tax for Q4 2025 was -$43.7 million at Fortress Biotech, down from $8.8 million in the prior quarter.
  • Over the last five years, Profit After Tax for FBIO hit a ceiling of $8.8 million in Q3 2025 and a floor of -$68.5 million in Q4 2021.
  • Median Profit After Tax over the past 5 years was -$24.4 million (2022), compared with a mean of -$26.9 million.
  • Biggest five-year swings in Profit After Tax: plummeted 505.37% in 2022 and later skyrocketed 133.07% in 2025.
  • Fortress Biotech's Profit After Tax stood at -$68.5 million in 2021, then increased by 16.15% to -$57.4 million in 2022, then surged by 49.54% to -$29.0 million in 2023, then grew by 9.21% to -$26.3 million in 2024, then plummeted by 65.94% to -$43.7 million in 2025.
  • The last three reported values for Profit After Tax were -$43.7 million (Q4 2025), $8.8 million (Q3 2025), and -$11.7 million (Q2 2025) per Business Quant data.